Pruritus in Pregnancy.
Journal
American journal of clinical dermatology
ISSN: 1179-1888
Titre abrégé: Am J Clin Dermatol
Pays: New Zealand
ID NLM: 100895290
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
accepted:
05
12
2021
pubmed:
23
2
2022
medline:
15
3
2022
entrez:
22
2
2022
Statut:
ppublish
Résumé
Pruritus in pregnancy is a common and burdensome symptom that may be a first sign of a pregnancy-specific pruritic disease (atopic eruption of pregnancy, polymorphic eruption of pregnancy, pemphigoid gestationis, and intrahepatic cholestasis in pregnancy) or a dermatosis coinciding with pregnancy by chance. Despite its high prevalence, pruritus is often underrated by physicians, and data regarding the safety profiles of drugs for pruritus are very limited. In this review, we illustrate the epidemiology, possible pathophysiology, clinical characteristics, and diagnostic workup of various pregnancy-related diseases and discuss antipruritic treatments. The prevalence of pruritus in pregnancy demonstrates the importance of symptom recognition and the need for an holistic approach, taking into account both the potential benefits for the patient and the potential risks to the fetus.
Identifiants
pubmed: 35191007
doi: 10.1007/s40257-021-00668-7
pii: 10.1007/s40257-021-00668-7
pmc: PMC8860374
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-246Informations de copyright
© 2022. The Author(s).
Références
Wong R, Ellis C. Physiologic skin changes in pregnancy. J Am Acad Dermatol. 1984;10:929–40. https://doi.org/10.1016/S0190-9622(84)80305-9 .
doi: 10.1016/S0190-9622(84)80305-9
pubmed: 6376552
Szczȩch J, Wiatrowski A, Hirnle L, Reich A. Prevalence and relevance of pruritus in pregnancy. Biomed Res Int. 2017. https://doi.org/10.1155/2017/4238139 .
doi: 10.1155/2017/4238139
pubmed: 29147651
pmcid: 5632889
Weisshaar E, Witteler R, Diepgen TL, Luger TA, Ständer S. Pruritus in pregnancy. A common diagnostic and therapeutic challenge. Hautarzt. 2005;56:48–57. https://doi.org/10.1007/s00105-004-0833-1 .
doi: 10.1007/s00105-004-0833-1
pubmed: 15536515
Dinatale M. The pregnancy and lactation labeling rule (PLLR) Division of Pediatric and Maternal Health FDA/CDER/OND/ODEIV Pediatric Advisory Committee Meeting. 2016.
Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol. 1997;15:35–43. https://doi.org/10.1016/S0738-081X(96)00108-3 .
doi: 10.1016/S0738-081X(96)00108-3
pubmed: 9034654
Kannambal K, Tharini GK. A screening study on dermatoses in pregnancy. J Clin Diagn Res. 2017;11:WC01-5. https://doi.org/10.7860/JCDR/2017/27207.9907 .
doi: 10.7860/JCDR/2017/27207.9907
pubmed: 28658887
pmcid: 5483789
Hajhashemi M, Rafieian M, Rouhi Boroujeni HA, Miraj S, Memarian S, Keivani A, et al. The effect of Aloe vera gel and sweet almond oil on striae gravidarum in nulliparous women. J Matern Neonatal Med. 2018;31:1703–8. https://doi.org/10.1080/14767058.2017.1325865 .
doi: 10.1080/14767058.2017.1325865
Ambros-Rudolph C, Müllegger R, Vaughan-Jones S, Kerl H, Black M. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54:395–404. https://doi.org/10.1016/J.JAAD.2005.12.012 .
doi: 10.1016/J.JAAD.2005.12.012
pubmed: 16488288
Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol. 1999;141:71–81. https://doi.org/10.1046/j.1365-2133.1999.02923.x .
doi: 10.1046/j.1365-2133.1999.02923.x
pubmed: 10417518
Akdis M, Trautmann A, Klunker S, Blaser K, Akdis CA. T cells and effector mechanisms in atopic dermatitis. In: New trends allergy V. Berlin: Springer; 2002. p. 113–20. https://doi.org/10.1007/978-3-642-55994-5_16 .
doi: 10.1007/978-3-642-55994-5_16
Ravelli FN, Goldust M, Kroumpouzos G (2020) Assessment of prurigo of pregnancy in patients without atopicbackground. Int J Womens Dermatol 6:384–389.
doi: 10.1016/j.ijwd.2020.06.011
Ambros-Rudolph CM, Sticherling M. Specific dermatoses of pregnancy. Hautarzt. 2017;68:87–94. https://doi.org/10.1007/S00105-016-3922-Z .
doi: 10.1007/S00105-016-3922-Z
pubmed: 28074212
Koutroulis I, Papoutsis J, Kroumpouzos G. Atopic dermatitis in pregnancy: current status and challenges. Obstet Gynecol Surv. 2011;66:654–63. https://doi.org/10.1097/OGX.0b013e31823a0908 .
doi: 10.1097/OGX.0b013e31823a0908
pubmed: 22112526
Treudler R. Allergic diseases in pregnancy. Overview of diagnosis and therapy. Hautarzt. 2010;61:1027–33. https://doi.org/10.1007/S00105-010-2008-6 .
doi: 10.1007/S00105-010-2008-6
pubmed: 21088817
Weisshaar E, Szepietowski JC, Dalgard F, Garcovich S, Gieler U, Gimenez-Arnau A et al (2019) European S2k guideline on chronic pruritus. Acta Derm Venereol 99:469–506.
doi: 10.2340/00015555-3164
Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol. 2014;70:401.e1-401.e14. https://doi.org/10.1016/j.jaad.2013.09.010 .
doi: 10.1016/j.jaad.2013.09.010
Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P, et al. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J Eur Acad Dermatol Venereol. 2019;33:1644–59. https://doi.org/10.1111/JDV.15709 .
doi: 10.1111/JDV.15709
pubmed: 31231864
Tsianakas A, Ständer S. Dupilumab: a milestone in the treatment of atopic dermatitis. Lancet. 2016;387:4–5. https://doi.org/10.1016/S0140-6736(15)00389-X .
doi: 10.1016/S0140-6736(15)00389-X
pubmed: 26454359
Andrews A-L, Holloway JW, Holgate ST, Davies DE. IL-4 receptor α is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol. 2006;176:7456–61. https://doi.org/10.4049/jimmunol.176.12.7456 .
doi: 10.4049/jimmunol.176.12.7456
pubmed: 16751391
Lobo Y, Lee RC, Spelman L. Atopic dermatitis treated safely with dupilumab during pregnancy: a case report and review of the literature. Case Rep Dermatol. 2021;13:248–56. https://doi.org/10.1159/000515246 .
doi: 10.1159/000515246
pubmed: 34177514
pmcid: 8215998
Mian M, Dunlap R, Simpson E. Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: a case report. JAAD Case Rep. 2020;6:1051–2. https://doi.org/10.1016/j.jdcr.2020.08.001 .
doi: 10.1016/j.jdcr.2020.08.001
pubmed: 32995444
pmcid: 7509357
Kroumpouzos G, Cohen LM. Specific dermatoses of pregnancy: an evidence-based systematic review. Am J Obstet Gynecol. 2003;188:1083–92. https://doi.org/10.1067/mob.2003.129 .
doi: 10.1067/mob.2003.129
pubmed: 12712115
Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol. 2001;45:1–22. https://doi.org/10.1067/mjd.2001.114595 .
doi: 10.1067/mjd.2001.114595
pubmed: 11423829
Moore MM, Rifas-Shiman SL, Rich-Edwards JW, Kleinman KP, Camargo CA, Gold DR, et al. Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics. 2004;113:468–74. https://doi.org/10.1542/peds.113.3.468 .
doi: 10.1542/peds.113.3.468
pubmed: 14993536
Dominguez-Serrano AJ, Quiroga-Garza A, Jacobo-Baca G, De La Fuente-Villarreal D, Gonzalez-Ramirez RA, Vazquez-Barragan MA, et al. Polymorphic eruption of pregnancy in Mexico. Int J Dermatol. 2019;58:259–62. https://doi.org/10.1111/ijd.14337 .
doi: 10.1111/ijd.14337
pubmed: 30549007
Ambros-Rudolph CM. Dermatoses of pregnancy—clues to diagnosis, fetal risk and therapy. Ann Dermatol. 2011;23:265–75. https://doi.org/10.5021/ad.2011.23.3.265 .
doi: 10.5021/ad.2011.23.3.265
pubmed: 21909194
pmcid: 3162253
Ghazeeri G, Kibbi AG, Abbas O. Pruritic urticarial papules and plaques of pregnancy: epidemiological, clinical, and histopathological study of 18 cases from Lebanon. Int J Dermatol. 2012;51:1047–53. https://doi.org/10.1111/j.1365-4632.2011.05203.x .
doi: 10.1111/j.1365-4632.2011.05203.x
pubmed: 22909357
Alcalay J, Ingber A, David M, Hazaz B, Sandbank M. Pruritic urticarial papules and plaques of pregnancy. A review of 21 cases. J Reprod Med Obstet Gynecol. 1987;32:315–6.
Rudolph CM, Al-Fares S, Vaughan-Jones SA, Müllegger RR, Kerl H, Black MM. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol. 2006;154:54–60. https://doi.org/10.1111/j.1365-2133.2005.06856.x .
doi: 10.1111/j.1365-2133.2005.06856.x
pubmed: 16403094
Regnier S, Fermand V, Levy P, Uzan S, Aractingi S. A case–control study of polymorphic eruption of pregnancy. J Am Acad Dermatol. 2008;58:63–7. https://doi.org/10.1016/j.jaad.2007.08.015 .
doi: 10.1016/j.jaad.2007.08.015
pubmed: 17884242
Petropoulou H, Georgala S, Katsambas AD. Polymorphic eruption of pregnancy. Int J Dermatol. 2006;45:642–8. https://doi.org/10.1111/J.1365-4632.2006.02715.X .
doi: 10.1111/J.1365-4632.2006.02715.X
pubmed: 16796619
Bohdanowicz M, Ghazarian D, Rosen CF. Targetoid form of polymorphic eruption of pregnancy: a case report. SAGE Open Med Case Rep. 2019;7:2050313X1988284. https://doi.org/10.1177/2050313x19882841 .
doi: 10.1177/2050313x19882841
Roth M-M. Pregnancy dermatoses: diagnosis, management, and controversies. Am J Clin Dermatol. 2011;12:25–42.
doi: 10.2165/11532010-000000000-00000
Özcan D, Özçakmak B, Aydoǧan FÇ. Polymorphic eruption of pregnancy with palmoplantar involvement that developed after delivery. J Obstet Gynaecol Res. 2011;37:1158–61. https://doi.org/10.1111/j.1447-0756.2010.01492.x .
doi: 10.1111/j.1447-0756.2010.01492.x
pubmed: 21501327
Radia C, Salim G, Kawtar I, Fatima Zahra M, Taoufiq H. Pemphigoid gestationis: a Moroccan study. Our Dermatol Online. 2017;8(2):128–32. https://doi.org/10.7241/ourd.20172.36 .
doi: 10.7241/ourd.20172.36
Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999;24:255–9. https://doi.org/10.1046/j.1365-2230.1999.00472.x .
doi: 10.1046/j.1365-2230.1999.00472.x
pubmed: 10457123
Al-Saif F, Elisa A, Al-Homidy A, Al-Ageel A, Al-Mubarak M. Retrospective analysis of pemphigoid gestationis in 32 Saudi patients—clinicopathological features and a literature review. J Reprod Immunol. 2016;116:42–5. https://doi.org/10.1016/j.jri.2016.04.286 .
doi: 10.1016/j.jri.2016.04.286
pubmed: 27175516
Hallaji Z, Mortazavi H, Ashtari S, Nikoo A, Abdollahi M, Nasimi M. Pemphigoid gestationis: clinical and histologic features of twenty-three patients. Int J Womens Dermatol. 2017;3:86. https://doi.org/10.1016/J.IJWD.2016.11.004 .
doi: 10.1016/J.IJWD.2016.11.004
pubmed: 28560301
Mokni M, Fourati M, Karoui I, El Euch D, Cherif F, Ben Tekaya N, et al. Pregnancy pemphigoid: study of 20 cases. Ann Dermatol Venereol. 2004;131:953–6. https://doi.org/10.1016/S0151-9638(04)93804-5 .
doi: 10.1016/S0151-9638(04)93804-5
pubmed: 15602381
Guerra L, Mazzanti C, Calabresi V, De Luca N, Zambruno G, Di Zenzo G. Pemphigoid gestationis complicating an egg donation pregnancy. Acta Derm Venereol. 2016;96:695–6. https://doi.org/10.2340/00015555-2303 .
doi: 10.2340/00015555-2303
pubmed: 26608214
Oms E, Tronnier M. Pemphigoid gestationis after egg donation: a case report. Hautarzt. 2020;71:223–6. https://doi.org/10.1007/S00105-019-04518-W .
doi: 10.1007/S00105-019-04518-W
pubmed: 31950210
Tillman WG. Herpes gestationis with hydatidiform mole and chorion epithelioma. Br Med J. 1950;1:1471. https://doi.org/10.1136/bmj.1.4668.1471 .
doi: 10.1136/bmj.1.4668.1471
pubmed: 15426779
pmcid: 2037952
Djahansouzi S, Nestle-Kraemling C, Dall P, Bender HG, Hanstein B. Herpes gestationis may present itself as a paraneoplastic syndrome of choriocarcinoma—a case report. Gynecol Oncol. 2003;89:334–7. https://doi.org/10.1016/S0090-8258(03)00070-2 .
doi: 10.1016/S0090-8258(03)00070-2
pubmed: 12714000
Do Valle Chiossi MP, Costa RS, Roselino AMF. Titration of herpes gestationis factor fixing to C3 in pemphigoid herpes gestationis associated with choriocarcinoma. Arch Dermatol. 2000;136:129–30. https://doi.org/10.1001/archderm.136.1.129-a .
doi: 10.1001/archderm.136.1.129-a
pubmed: 10632227
Inani K, Meziane M, Bouyahyaoui Y, Mernissi FZ, Sekal M, Harmouch T, et al. Choriocarcinoma: a hidden face of gestational pemphigoid. Gynecol Obstet Fertil. 2014;42:357–9. https://doi.org/10.1016/j.gyobfe.2013.11.003 .
doi: 10.1016/j.gyobfe.2013.11.003
pubmed: 24411341
Takatsuka Y, Komine M, Ohtsuki M. Pemphigoid gestationis with a complete hydatidiform mole. J Dermatol. 2012;39:474–6. https://doi.org/10.1111/j.1346-8138.2011.01315.x .
doi: 10.1111/j.1346-8138.2011.01315.x
pubmed: 21950371
Matsumoto N, Osada M, Kaneko K, Ohara K, Noguchi D, Udagawa H, et al. Pemphigoid gestationis after spontaneous expulsion of a massive complete hydatidiform mole. Case Rep Obstet Gynecol. 2013;2013:1–5. https://doi.org/10.1155/2013/267268 .
doi: 10.1155/2013/267268
Slazinski L, Degefu S. Herpes gestationis associated with choriocarcinoma. Arch Dermatol. 1982;118:425–8. https://doi.org/10.1001/archderm.1982.01650180059019 .
doi: 10.1001/archderm.1982.01650180059019
pubmed: 7046639
Shornick JK, Bangert JL, Freeman RG, Gilliam JN. Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol. 1983;8:214–24. https://doi.org/10.1016/S0190-9622(83)70027-7 .
doi: 10.1016/S0190-9622(83)70027-7
pubmed: 6338065
Kolodny RC. Herpes gestationis. A new assessment of incidence, diagnosis, and fetal prognosis. Am J Obstet Gynecol. 1969;104:39–45. https://doi.org/10.1016/S0002-9378(16)34138-2 .
doi: 10.1016/S0002-9378(16)34138-2
pubmed: 5777701
Tani N, Kimura Y, Koga H, Kawakami T, Ohata C, Ishii N, et al. Clinical and immunological profiles of 25 patients with pemphigoid gestationis. Br J Dermatol. 2015;172:120–9. https://doi.org/10.1111/bjd.13374 .
doi: 10.1111/bjd.13374
pubmed: 25154546
Huilaja L, Mäkikallio K, Sormunen R, Lohi J, Hurskainen T, Tasanen K. Gestational pemphigoid: placental morphology and function. Acta Derm Venereol. 2013;93:33–8. https://doi.org/10.2340/00015555-1370 .
doi: 10.2340/00015555-1370
pubmed: 22565610
Montagnon CM, Tolkachjov SN, Murrell DF, Camilleri MJ, Lehman JS. Subepithelial autoimmune blistering dermatoses: clinical features and diagnosis. J Am Acad Dermatol. 2021;85:1–14. https://doi.org/10.1016/j.jaad.2020.11.076 .
doi: 10.1016/j.jaad.2020.11.076
pubmed: 33684496
Semkova K, Black M. Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol. 2009;145:138–44. https://doi.org/10.1016/j.ejogrb.2009.05.012 .
doi: 10.1016/j.ejogrb.2009.05.012
pubmed: 19520487
Intong LRA, Murrell DF. Pemphigoid gestationis: pathogenesis and clinical features. Dermatol Clin. 2011;29:447–52. https://doi.org/10.1016/j.det.2011.03.002 .
doi: 10.1016/j.det.2011.03.002
pubmed: 21605810
Al Saif F, Jouen F, Hebert V, Chiavelli H, Darwish B, Duvert-Lehembre S, et al. Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. J Am Acad Dermatol. 2017;76:560–2. https://doi.org/10.1016/j.jaad.2016.09.030 .
doi: 10.1016/j.jaad.2016.09.030
pubmed: 28212762
Powell AM, Sakuma-Oyama Y, Oyama N, Albert S, Bhogal B, Kaneko F, et al. Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy. Arch Dermatol. 2005;141:705–10. https://doi.org/10.1001/archderm.141.6.705 .
doi: 10.1001/archderm.141.6.705
pubmed: 15967916
Sitaru C, Powell J, Messer G, Bröcker EB, Wojnarowska F, Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol. 2004;103:757–63. https://doi.org/10.1097/01.AOG.0000115506.76104.ad .
doi: 10.1097/01.AOG.0000115506.76104.ad
pubmed: 15051570
Ceryn J, Siekierko A, Skibińska M, Doss N, Narbutt J, Lesiak A. Pemphigoid gestationis—case report and review of literature. Clin Cosmet Investig Dermatol. 2021;14:665–70. https://doi.org/10.2147/ccid.s297520 .
doi: 10.2147/ccid.s297520
pubmed: 34168478
pmcid: 8218239
Fania L, Guerriero C, Ricci F, Gagliano MF, De Simone C. Herpes gestationis and oral contraceptive: case report and review of the literature. Dermatol Ther. 2017. https://doi.org/10.1111/dth.12518 .
doi: 10.1111/dth.12518
pubmed: 28730612
Patsatsi A, Marinovic B, Murrell D. Autoimmune bullous diseases during pregnancy: solving common and uncommon issues. Int J Womens Dermatol. 2019;5:166. https://doi.org/10.1016/J.IJWD.2019.01.003 .
doi: 10.1016/J.IJWD.2019.01.003
pubmed: 31360750
pmcid: 6637227
Gregurek-Novak T. Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2001;15:81–2. https://doi.org/10.1046/J.1468-3083.2001.00176-5.X .
doi: 10.1046/J.1468-3083.2001.00176-5.X
pubmed: 11451336
Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, et al. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration. Australas J Dermatol. 2018;59:86–100. https://doi.org/10.1111/AJD.12641 .
doi: 10.1111/AJD.12641
pubmed: 28543445
Kushner CJ, Concha JSS, Werth VP. Treatment of autoimmune bullous disorders in pregnancy. Am J Clin Dermatol. 2018;19:391–403. https://doi.org/10.1007/s40257-018-0342-0 .
doi: 10.1007/s40257-018-0342-0
pubmed: 29392620
Sciascia S, Baldovino S, Ribero S, Marzano AV, Genovese G, Derlino F, et al. A systematic review of treatment options and clinical outcomes in pemphigoid gestationis. Front Med. 2020;7: 604945. https://doi.org/10.3389/fmed.2020.604945 .
doi: 10.3389/fmed.2020.604945
Patel PM, Jones VA, Murray TN, Amber KT. A review comparing international guidelines for the management of bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, and epidermolysis bullosa acquisita. Am J Clin Dermatol. 2020;21:557–65. https://doi.org/10.1007/s40257-020-00513-3 .
doi: 10.1007/s40257-020-00513-3
pubmed: 32180161
Yang A, Uhlenhake E, Murrell DF. Pemphigoid gestationis and intravenous immunoglobulin therapy. Int J Womens Dermatol. 2018;4:166–9. https://doi.org/10.1016/j.ijwd.2018.03.007 .
doi: 10.1016/j.ijwd.2018.03.007
pubmed: 30175219
pmcid: 6116823
Nguyen T, Alraqum E, Razzaque AA. Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis. Int Immunopharmacol. 2015;26:1–3. https://doi.org/10.1016/j.intimp.2015.02.038 .
doi: 10.1016/j.intimp.2015.02.038
pubmed: 25765353
Killion L, Beatty P, Tierney E, Hackett C, Tobin AM, O’Brennan E. Severe pemphigoid gestationis responsive to intravenous immunoglobulins after initial treatment failure of combined oral steroids and cyclosporin. Eur J Dermatol. 2021;31:245–6. https://doi.org/10.1684/ejd.2021.4006 .
doi: 10.1684/ejd.2021.4006
pubmed: 34001471
Boria F, Maseda R, Albízuri F, de la Calle M. Intravenous immunoglobulin therapy for gestational pemphigoid refractory to conventional treatment. Actas Dermosifiliogr. 2021;112:83–5. https://doi.org/10.1016/j.ad.2019.04.016 .
doi: 10.1016/j.ad.2019.04.016
pubmed: 32986975
Almeida FT, Sarabando R, Pardal J, Brito C. Pemphigoid gestationis successfully treated with intravenous immunoglobulin. BMJ Case Rep. 2018. https://doi.org/10.1136/bcr-2018-224346 .
doi: 10.1136/bcr-2018-224346
pubmed: 30007908
pmcid: 6047724
De la Calle M, Vidaurrázaga C, Martinez N, González-Beato M, Antolín E, Bartha JL. Successful treatment of a severe early onset case of pemphigoid gestationis with intravenous immunoglobulin in a twin pregnancy conceived with in vitro fertilisation in a primigravida. J Obstet Gynaecol. 2017;37:246–7. https://doi.org/10.1080/01443615.2016.1244809 .
doi: 10.1080/01443615.2016.1244809
pubmed: 27922278
Ko BJ, Whang KU. Intravenous immunoglobulin therapy for persistent pemphigoid gestationis with steroid induced iatrogenic Cushing’s syndrome. Ann Dermatol. 2014;26:661–3. https://doi.org/10.5021/ad.2014.26.5.661 .
doi: 10.5021/ad.2014.26.5.661
pubmed: 25324672
pmcid: 4198607
Hapa A, Gurpinar A, Akan T, Gokoz O. A resistant case of pemphigus gestationis successfully treated with intravenous immunoglobulin plus cyclosporine. Int J Dermatol. 2014. https://doi.org/10.1111/ijd.12128 .
doi: 10.1111/ijd.12128
pubmed: 23879601
Prussick R, Ali MAM, Rosenthal D, Guyatt G. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis. Arch Dermatol. 1992;128:210–3. https://doi.org/10.1001/ARCHDERM.1992.01680120082007 .
doi: 10.1001/ARCHDERM.1992.01680120082007
pubmed: 1739299
Tourte M, Brunet-Possenti F, Mignot S, Gavard L, Descamps V. Pemphigoid gestationis: a successful preventive treatment by rituximab. J Eur Acad Dermatol Venereol. 2017;31:e206–7. https://doi.org/10.1111/jdv.13962 .
doi: 10.1111/jdv.13962
pubmed: 27606493
Leroy C, Rigot JM, Leroy M, Decanter C, Le Mapihan K, Parent AS, et al. Immunosuppressive drugs and fertility. Orphanet J Rare Dis. 2015;10:1–15. https://doi.org/10.1186/s13023-015-0332-8 .
doi: 10.1186/s13023-015-0332-8
Chi CC, Wang SH, Charles-Holmes R, Ambros-Rudolph C, Powell J, Jenkins R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol. 2009;160:1222–8. https://doi.org/10.1111/J.1365-2133.2009.09086.X .
doi: 10.1111/J.1365-2133.2009.09086.X
pubmed: 19298272
Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018;231:180–7. https://doi.org/10.1016/J.EJOGRB.2018.10.041 .
doi: 10.1016/J.EJOGRB.2018.10.041
pubmed: 30396107
Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med. 1978;88:487–93. https://doi.org/10.7326/0003-4819-88-4-487 .
doi: 10.7326/0003-4819-88-4-487
pubmed: 637428
Lee RH, Goodwin TM, Greenspoon J, Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol. 2006;26:527–32. https://doi.org/10.1038/sj.jp.7211545 .
doi: 10.1038/sj.jp.7211545
pubmed: 16761011
Kenyon AP, Tribe RM, Nelson-Piercy C, Girling JC, Williamson C, Seed PT, et al. Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstet Med. 2010;3:25. https://doi.org/10.1258/OM.2010.090055 .
doi: 10.1258/OM.2010.090055
pubmed: 27582836
pmcid: 4989767
Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JCG. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med. 2001;10:131–5. https://doi.org/10.1080/714052719 .
doi: 10.1080/714052719
pubmed: 11392594
Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health. 1999;4:35–7. https://doi.org/10.1080/13557859998173 .
doi: 10.1080/13557859998173
pubmed: 10887460
Kremer AE, Wolf K, Ständer S. Intrahepatic pregnancy cholestasis: rare but relevant. Hautarzt. 2017;68:95–102. https://doi.org/10.1007/s00105-016-3923-y .
doi: 10.1007/s00105-016-3923-y
pubmed: 28074213
Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000;33:1012–21. https://doi.org/10.1016/S0168-8278(00)80139-7 .
doi: 10.1016/S0168-8278(00)80139-7
pubmed: 11131439
Xiao J, Li Z, Song Y, Sun Y, Shi H, Chen D, et al. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Can J Gastroenterol Hepatol. 2021. https://doi.org/10.1155/2021/6679322 .
doi: 10.1155/2021/6679322
pubmed: 34195157
pmcid: 8181114
Kirkinen P, Ylöstalo P, Heikkinen J, Mäentausta O. Gallbladder function and maternal bile acids in intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol. 1984;18:29–34. https://doi.org/10.1016/0028-2243(84)90030-3 .
doi: 10.1016/0028-2243(84)90030-3
pubmed: 6500148
Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomäki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology. 2006;43:723–8. https://doi.org/10.1002/hep.21111 .
doi: 10.1002/hep.21111
pubmed: 16557542
Locatelli A, Roncaglia N, Arreghini A, Bellini P, Vergani P, Ghidini A. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. BJOG An Int J Obstet Gynaecol. 1999;106:498–500. https://doi.org/10.1111/j.1471-0528.1999.tb08305.x .
doi: 10.1111/j.1471-0528.1999.tb08305.x
Paternoster DM, Fabris F, Palù G, Santarossa C, Bracciante R, Snijders D, et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand. 2002;81:99–103. https://doi.org/10.1034/J.1600-0412.2002.810202.X .
doi: 10.1034/J.1600-0412.2002.810202.X
pubmed: 11942897
Marathe JA, Lim WH, Metz MP, Scheil W, Dekker GA, Hague WM. A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population. Eur J Obstet Gynecol Reprod Biol. 2017;218:33–8. https://doi.org/10.1016/j.ejogrb.2017.09.012 .
doi: 10.1016/j.ejogrb.2017.09.012
pubmed: 28926728
Martineau M, Raker C, Powrie R, Williamson C. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2014;176:80–5. https://doi.org/10.1016/j.ejogrb.2013.12.037 .
doi: 10.1016/j.ejogrb.2013.12.037
pubmed: 24462052
Wikström Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. An Int J Obstet Gynaecol. 2013;120:717–23. https://doi.org/10.1111/1471-0528.12174 .
doi: 10.1111/1471-0528.12174
Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists: relevant after all these years. Med Hypotheses. 2018;110:86–9. https://doi.org/10.1016/j.mehy.2017.11.002 .
doi: 10.1016/j.mehy.2017.11.002
pubmed: 29317077
Wongjarupong N, Bharmal S, Lim N. Never too soon: an unusual case of intrahepatic cholestasis of pregnancy at five weeks gestation. Cureus. 2020. https://doi.org/10.7759/cureus.10540 .
doi: 10.7759/cureus.10540
pubmed: 33094079
pmcid: 7574978
Koh K, Kathirvel R, Mathur M. Rare case of obstetric cholestasis presenting in the first trimester following in vitro fertilisation. BMJ Case Rep. 2021;14: e244254. https://doi.org/10.1136/BCR-2021-244254 .
doi: 10.1136/BCR-2021-244254
pubmed: 34233868
Meier Y, Zodan T, Lang C, Zimmermann R, Kullak-Ublick G, Meier P, et al. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World J Gastroenterol. 2008;14:38–45. https://doi.org/10.3748/WJG.14.38 .
doi: 10.3748/WJG.14.38
pubmed: 18176959
pmcid: 2673389
Zhan Q, Qi X, Weng R, Xi F, Chen Y, Wang Y, et al. Alterations of the human gut microbiota in intrahepatic cholestasis of pregnancy. Front Cell Infect Microbiol. 2021. https://doi.org/10.3389/fcimb.2021.635680 .
doi: 10.3389/fcimb.2021.635680
pubmed: 34796121
pmcid: 8593038
Zipori Y, Bachar G, Farago N, Lauterbach R, Weissman A, Beloosesky R, et al. Vaginal progesterone treatment for the prevention of preterm birth and intrahepatic cholestasis of pregnancy: a case–control study. Eur J Obstet Gynecol Reprod Biol. 2020;253:117–20. https://doi.org/10.1016/j.ejogrb.2020.08.043 .
doi: 10.1016/j.ejogrb.2020.08.043
pubmed: 32866855
Zhang X, Chen Y, Salerno S, Li Y, Zhou L, Zeng X, et al. Prediction of intrahepatic cholestasis of pregnancy in the first 20 weeks of pregnancy. J Matern Fetal Neonatal Med. 2021. https://doi.org/10.1080/14767058.2021.1911996 .
doi: 10.1080/14767058.2021.1911996
pubmed: 34961407
Roszkowski I, Pisarek-Miedzińska D. Jaundice in pregnancy: II. Clinical course of pregnancy and delivery and condition of neonate. Am J Obstet Gynecol. 1968;101:500–3. https://doi.org/10.1016/0002-9378(68)90559-0 .
doi: 10.1016/0002-9378(68)90559-0
pubmed: 5655394
de Swiet M. Medical disorders in obstetric practice. Oxford: Blackwell Publishing; 2002.
doi: 10.1002/9780470752371
EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237–67. https://doi.org/10.1016/J.JHEP.2009.04.009 .
Walker KF, Chappell LC, Hague WM, Middleton P, Thornton JG. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev. 2020;7(7):CD000493. https://doi.org/10.1002/14651858.CD000493.pub3 .
doi: 10.1002/14651858.CD000493.pub3
pubmed: 32716060
Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019;394:849–60. https://doi.org/10.1016/S0140-6736(19)31270-X .
doi: 10.1016/S0140-6736(19)31270-X
pubmed: 31378395
pmcid: 6739598
Hagenbeck C, Hamza A, Kehl S, Maul H, Lammert F, Keitel V, et al. Management of intrahepatic cholestasis of pregnancy: recommendations of the Working Group on Obstetrics and Prenatal Medicine—section on maternal disorders. Geburtshilfe Frauenheilkd. 2021;81:922. https://doi.org/10.1055/A-1386-3912 .
doi: 10.1055/A-1386-3912
pubmed: 34393256
pmcid: 8354365
Geenes V, Chambers J, Khurana R, Shemer EW, Sia W, Mandair D, et al. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2015;189:59–63. https://doi.org/10.1016/j.ejogrb.2015.03.020 .
doi: 10.1016/j.ejogrb.2015.03.020
pubmed: 25864112
Rezai S, Gallo D, Payero E, Henderson CE. Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2019;133:384–5. https://doi.org/10.1097/AOG.0000000000003095 .
doi: 10.1097/AOG.0000000000003095
pubmed: 30681532
Liu J, Murray AM, Mankus EB, Ireland KE, Acosta OM, Ramsey PS. Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2018;132:678–81. https://doi.org/10.1097/AOG.0000000000002794 .
doi: 10.1097/AOG.0000000000002794
pubmed: 30095766
Liu J, Murray AM, Mankus EB, Ireland KE, Acosta OM, Ramsey PS. In reply. Obstet Gynecol. 2019;133:385. https://doi.org/10.1097/AOG.0000000000003096 .
doi: 10.1097/AOG.0000000000003096
pubmed: 30681533
Gaudet R, Merviel P, Berkane N, Schouppe S, Cocheton JJ, Uzan S. Fetal impact of cholestasis of pregnancy: experience at Tenon Hospital and literature review. Fetal Diagn Ther. 2000;15:191–7. https://doi.org/10.1159/000021005 .
doi: 10.1159/000021005
pubmed: 10867478
Williamson C, Miragoli M, Kadir SSA, Abu-Hayyeh S, Papacleovoulou G, Geenes V, et al. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy. Dig Dis. 2011;29:58–61. https://doi.org/10.1159/000324130 .
doi: 10.1159/000324130
pubmed: 21691106
Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol. 1996;175:957–60. https://doi.org/10.1016/S0002-9378(96)80031-7 .
doi: 10.1016/S0002-9378(96)80031-7
pubmed: 8885754
Davies MH, Da Silva RCMA, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut. 1995;37:580–4. https://doi.org/10.1136/gut.37.4.580 .
doi: 10.1136/gut.37.4.580
pubmed: 7489950
pmcid: 1382915
Lambert J. Itch in pregnancy management. Curr Probl Dermatol. 2016;50:164–72. https://doi.org/10.1159/000446087 .
doi: 10.1159/000446087
pubmed: 27578086
Jones SV, Ambros-Rudolph C, Nelson-Piercy C. Skin disease in pregnancy. BMJ. 2014. https://doi.org/10.1136/bmj.g3489 .
doi: 10.1136/bmj.g3489
pubmed: 25552260
pmcid: 4157615
del Carpio-Orantes L, Rosas-Lozano AL, García-Méndez S. Zika virus infection in pregnant women in a General Hospital of Veracruz, Mexico. J Matern Neonatal Med. 2020;33:3627–31. https://doi.org/10.1080/14767058.2019.1582627 .
doi: 10.1080/14767058.2019.1582627
Stefaniak AA, Białynicki-Birula R, Krajewski PK, Matusiak Ł, Goldust M, Szepietowski JC. Itch in the era of COVID-19 pandemic: an unfolding scenario. Dermatol Ther. 2020. https://doi.org/10.1111/dth.13477 .
doi: 10.1111/dth.13477
pubmed: 32358869
pmcid: 7261994
Weisshaar E, Diepgen TL, Luger TA, Seeliger S, Witteler R, Ständer S. Pruritus in pregnancy and childhood—do we really consider all relevant differential diagnoses? Eur J Dermatol. 2005;15:320–31.
pubmed: 16172038
Kolitz E, Gammon L, Mauskar M. Vulvar lichen sclerosus in women of reproductive age. Baylor Univ Med Cent Proc. 2021;34:349–51. https://doi.org/10.1080/08998280.2021.1885093 .
doi: 10.1080/08998280.2021.1885093
Estevinho C, Soares E, Carvalho AP, Costa F. Vulvar pruritus. BMJ Case Rep. 2020;13: e240048. https://doi.org/10.1136/bcr-2020-240048 .
doi: 10.1136/bcr-2020-240048
pubmed: 33384348
Akarsu S, Ozbagcivan O, Ilknur T, Semiz F, Inci BB, Fetil E. Xerosis cutis and associated co-factors in women with prurigo nodularis. An Bras Dermatol. 2018;93:671–9. https://doi.org/10.1590/abd1806-4841.20187127 .
doi: 10.1590/abd1806-4841.20187127
pubmed: 30156616
pmcid: 6106662
Sakai S, Kikuchi K, Satoh J, Tagami H, Inoue S. Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. Br J Dermatol. 2005;153:319–23. https://doi.org/10.1111/j.1365-2133.2005.06756.x .
doi: 10.1111/j.1365-2133.2005.06756.x
pubmed: 16086742
Seité S, Khemis A, Rougier A, Ortonne J. Importance of treatment of skin xerosis in diabetes. J Eur Acad Dermatol Venereol. 2011;25:607–9. https://doi.org/10.1111/j.1468-3083.2010.03807.x .
doi: 10.1111/j.1468-3083.2010.03807.x
pubmed: 21492247
Stefaniak A, Chlebicka I, Szepietowski J. Itch in diabetes: a common underestimated problem. Adv Dermatol Allergol. 2019. https://doi.org/10.5114/ada.2019.89712 .
doi: 10.5114/ada.2019.89712
Nikolajuk-Stasiuk J, Lapinski TW. The influence of hepatitis B virus (Hbv) or hepatitis C virus (Hcv) infections on the pregnancy course. Ginekol Pol. 2021;92:30–4. https://doi.org/10.5603/GP.A2020.0139 .
doi: 10.5603/GP.A2020.0139
pubmed: 33576489
Chi C, Wang S, Wojnarowska F, Kirtschig G, Davies E, Bennett C. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2015;2015(10):CD007346. https://doi.org/10.1002/14651858.CD007346.PUB3 .
doi: 10.1002/14651858.CD007346.PUB3
pmcid: 8558096
Chi CC, Wang SH, Mayon-White R, Wojnarowska F. Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study. JAMA Dermatol. 2013;149:1274–80. https://doi.org/10.1001/jamadermatol.2013.5768 .
doi: 10.1001/jamadermatol.2013.5768
pubmed: 24005903
Gilbert C, Mazzotta P, Loebstein R, Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf. 2005;28:707–19. https://doi.org/10.2165/00002018-200528080-00005 .
doi: 10.2165/00002018-200528080-00005
pubmed: 16048356
Moretti ME, Caprara D, Coutinho CJ, Bar-Oz B, Berkovitch M, Addis A, et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol. 2003;111:479–83. https://doi.org/10.1067/mai.2003.130 .
doi: 10.1067/mai.2003.130
pubmed: 12642825
Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol. 1997;78:157–9. https://doi.org/10.1016/S1081-1206(10)63382-0 .
doi: 10.1016/S1081-1206(10)63382-0
pubmed: 9048523
Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Neonatal Med. 2002;11:146–52. https://doi.org/10.1080/jmf.11.3.146.152 .
doi: 10.1080/jmf.11.3.146.152
Hansen C, Desrosiers TA, Wisniewski K, Strickland MJ, Werler MM, Gilboa SM. Use of antihistamine medications during early pregnancy and selected birth defects: The National Birth Defects Prevention Study, 1997–2011. Birth Defects Res. 2020;112:1234–52. https://doi.org/10.1002/bdr2.1749 .
doi: 10.1002/bdr2.1749
pubmed: 32657014
Andersson NW, Torp-Pedersen C, Andersen JT. Association between fexofenadine use during pregnancy and fetal outcomes. JAMA Pediatr. 2020. https://doi.org/10.1001/jamapediatrics.2020.1316 .
doi: 10.1001/jamapediatrics.2020.1316
pubmed: 32478810
pmcid: 7265125
Andersson NW, Poulsen HE, Andersen JT. Desloratadine use during pregnancy and risk of adverse fetal outcomes: a Nationwide cohort study. J Allergy Clin Immunol Pract. 2020;8:1598–605. https://doi.org/10.1016/j.jaip.2020.02.017 .
doi: 10.1016/j.jaip.2020.02.017
pubmed: 32142963
Zhang M, Goyert G, Lim HW. Folate and phototherapy: what should we inform our patients? J Am Acad Dermatol. 2017;77:958–64. https://doi.org/10.1016/j.jaad.2016.10.016 .
doi: 10.1016/j.jaad.2016.10.016
pubmed: 29029903
Park KK, Murase JE. Narrowband UV-B phototherapy during pregnancy and folic acid depletion. Arch Dermatol. 2012;148:132–3. https://doi.org/10.1001/archdermatol.2011.1614 .
doi: 10.1001/archdermatol.2011.1614
pubmed: 22250254
Kebria AS, Hosseini M, Khafri S. The effect of narrowband ultraviolet B phototherapy on serum folate level. Casp J Intern Med. 2021;12:180–3. https://doi.org/10.22088/cjim.12.2.180 .
doi: 10.22088/cjim.12.2.180
Ortonne J, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23:1254–62. https://doi.org/10.1111/J.1468-3083.2009.03295.X .
doi: 10.1111/J.1468-3083.2009.03295.X
pubmed: 19486232
Pinsky L, Digeorce AM. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science. 1965;147:402–3. https://doi.org/10.1126/science.147.3656.402 .
doi: 10.1126/science.147.3656.402
pubmed: 14221487
Park-Wyllie L, Mazzota P, Pastuszak A, Moretti ME, Beique L, Hunnisett L et al (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385–392.
doi: 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z
Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18:93–101. https://doi.org/10.1016/j.reprotox.2003.10.007 .
doi: 10.1016/j.reprotox.2003.10.007
pubmed: 15013068
Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005;365:1856–62. https://doi.org/10.1016/S0140-6736(05)66617-2 .
doi: 10.1016/S0140-6736(05)66617-2
pubmed: 15924982
Øtensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8:1–19. https://doi.org/10.1186/ar1957 .
doi: 10.1186/ar1957
Prévot A, Martini S, Guignard JP. In utero exposure to immunosuppressive drugs. Biol Neonate. 2002;81:73–81. https://doi.org/10.1159/000047187 .
doi: 10.1159/000047187
pubmed: 11844873
Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol. 2004;99:656–61. https://doi.org/10.1111/j.1572-0241.2004.04140.x .
doi: 10.1111/j.1572-0241.2004.04140.x
pubmed: 15089898
Nørgård B, Pedersen L, Christensen LA, Sørensen HT. Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish Nationwide Cohort Study. Am J Gastroenterol. 2007;102:1406–13. https://doi.org/10.1111/j.1572-0241.2007.01216.x .
doi: 10.1111/j.1572-0241.2007.01216.x
pubmed: 17437503
Cleary BJ, Källén B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res Part A Clin Mol Teratol. 2009;85:647–54. https://doi.org/10.1002/BDRA.20583 .
doi: 10.1002/BDRA.20583
McCormack PL. Omalizumab: a review of its use in patients with chronic spontaneous urticaria. Drugs. 2014;74:1693–9. https://doi.org/10.1007/s40265-014-0290-9 .
doi: 10.1007/s40265-014-0290-9
pubmed: 25217402
Losappio LM, Mirone C, Schroeder JW, Scibilia J, Balossi L, Pastorello EA. Omalizumab use in chronic spontaneous urticaria during pregnancy and a four years’ follow-up: a case report. Case Rep Dermatol. 2020;12:174–7. https://doi.org/10.1159/000509179 .
doi: 10.1159/000509179
pubmed: 33173477
pmcid: 7588681
Namazy J, Cabana MD, Scheuerle AE, Thorp JM, Chen H, Carrigan G, et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol. 2015;135:407–12. https://doi.org/10.1016/j.jaci.2014.08.025 .
doi: 10.1016/j.jaci.2014.08.025
pubmed: 25441639
Namazy JA, Blais L, Andrews EB, Scheuerle AE, Cabana MD, Thorp JM, et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol. 2020;145:528-536.e1. https://doi.org/10.1016/j.jaci.2019.05.019 .
doi: 10.1016/j.jaci.2019.05.019
pubmed: 31145939
Jacob SE, Steele T. Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity. J Am Acad Dermatol. 2006;54:723–7. https://doi.org/10.1016/J.JAAD.2005.12.028 .
doi: 10.1016/J.JAAD.2005.12.028
pubmed: 16546601
British Association of Dermatologists. The British Association of Dermatologists’ information on topical corticosteroids—established and alternative proprietary names, potency, and discontinuation. London: British Association of Dermatologists; June 2015. https://www.bad.org.uk/shared/get-file.ashx?id=3427&itemtype=document . Accessed 17 Oct 2021.